Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag In March 2026, Medtronic’s MiniMed went public to advance wearable insulin pumps amid rising diabetes rates and market growth.

flag The global pen needles market is projected to grow from $3.5 billion in 2023 to $8.5 billion by 2031, driven by rising diabetes rates, home healthcare adoption, and innovations like ultra-fine, shorter needles and smart device compatibility. flag Meanwhile, the insulin syringes market is expected to rise from $1.56 billion in 2020 to $2.40 billion by 2030, supported by diabetes prevalence and improved access. flag In March 2026, Medtronic’s MiniMed division went public to fund next-gen wearable insulin delivery systems, while Insulet and Modular Medical advanced their automated and low-cost patch pumps. flag Disposable insulin pumps are growing rapidly, with open-loop systems dominating the U.S. market, and North America leading globally due to innovation and infrastructure.

3 Articles